T. Rowe Price Associates’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.4M | Sell |
|
|||||
|
2025
Q1 | $32.7M | Sell |
|
|||||
|
2024
Q4 | $41.8M | Sell |
|
|||||
|
2024
Q3 | $43.9M | Sell |
|
|||||
|
2024
Q2 | $63.5M | Sell |
|
|||||
|
2024
Q1 | $104M | Buy |
|
|||||
|
2023
Q4 | $77.5M | Sell |
|
|||||
|
2023
Q3 | $64.5M | Sell |
|
|||||
|
2023
Q2 | $78.1M | Sell |
|
|||||
|
2023
Q1 | $61.5M | Sell |
|
|||||
|
2022
Q4 | $72.6M | Sell |
|
|||||
|
2022
Q3 | $56.4M | Sell |
|
|||||
|
2022
Q2 | $58.3M | Sell |
|
|||||
|
2022
Q1 | $78.2M | Sell |
|
|||||
|
2021
Q4 | $107M | Sell |
|
|||||
|
2021
Q3 | $97.1M | Sell |
|
|||||
|
2021
Q2 | $124M | Sell |
|
|||||
|
2021
Q1 | $124M | Sell |
|
|||||
|
2020
Q4 | $109M | Sell |
|
|||||
|
2020
Q3 | $88M | Buy |
|
|||||
|
2020
Q2 | $72.9M | Buy |
|
|||||
|
2020
Q1 | $57.4M | Buy |
|
|||||
|
2019
Q4 | $64M | Buy |
|
|||||
|
2019
Q3 | $62.3M | Buy |
|
|||||
|
2019
Q2 | $37.9M | Buy |
|
|||||
|
2019
Q1 | $17.4M | Buy |
|
|||||
|
2018
Q4 | $273K | Buy |
|
|||||
|
2018
Q3 | $290K | Buy |
|